Greenwood Capital Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,324
Closed -$529K 197
2019
Q2
$529K Sell
6,324
-379
-6% -$30.2K 0.13% 95
2019
Q1
$530K Buy
6,703
+19
+0.3% +$1.39K 0.14% 90
2018
Q4
$446K Buy
6,684
+414
+7% +$28.6K 0.12% 102
2018
Q3
$501K Buy
6,270
+2,560
+69% +$191K 0.11% 108
2018
Q2
$250K Buy
+3,710
New +$269K 0.06% 166

Other funds holding XYL

Greenwood Capital Associates's XYL Position: Q3 2019 in Review

Greenwood Capital Associates sold out of Xylem (XYL) in Q3 2019, closing a stake of 6,324 shares — an estimated $529K sold.

Greenwood Capital Associates first reported a position in XYL in Q2 2018 and held it in 5 quarters. The position peaked at $530K in Q1 2019. 677 funds tracked by Wall St. Rank hold XYL as of Q3 2019.

  • Greenwood Capital Associates reported no remaining Xylem position as of Q3 2019 after selling out during the quarter.
  • Greenwood Capital Associates sold 6,324 Xylem shares in Q3 2019, an estimated $529K.
  • Greenwood Capital Associates first reported a position in Xylem in Q2 2018 and held it in 5 quarters.
  • Greenwood Capital Associates's Xylem position peaked at $530K in Q1 2019.
  • 677 funds tracked by Wall St. Rank held Xylem as of Q3 2019.

Based on Greenwood Capital Associates's 13F filing for Q3 2019, filed 12 Nov 2019.